IBT
ASXC

International Biotechnology Trust’s Asensus Surgical, Inc. ASXC Stock Holding History

International Biotechnology Trust’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-68,391
Closed -$3.82M – 56
2018
Q2 		$3.82M Hold
68,391
– – 1.47% 23
2018
Q1 		$1.5M Hold
68,391
– – 0.59% 38
2017
Q4 		$1.71M Hold
68,391
– – 0.6% 42
2017
Q3 		$1.27M Hold
68,391
– – 0.49% 42
2017
Q2 		$625K Hold
68,391
– – 0.24% 57
2017
Q1 		$1.08M Hold
68,391
– – 0.41% 48
2016
Q4 		$1.16M Buy
+68,391
New +$1.4M 0.52% 36

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Biotechnology Trust's ASXC Position: Q3 2018 in Review

International Biotechnology Trust sold out of Asensus Surgical, Inc. (ASXC) in Q3 2018, closing a stake of 68,391 shares — an estimated $3.82M sold.

International Biotechnology Trust first reported a position in ASXC in Q4 2016 and held it in 7 quarters. The position peaked at $3.82M in Q2 2018. 151 funds tracked by Wall St. Rank hold ASXC as of Q3 2018.

  • International Biotechnology Trust reported no remaining Asensus Surgical, Inc. position as of Q3 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 68,391 Asensus Surgical, Inc. shares in Q3 2018, an estimated $3.82M.
  • International Biotechnology Trust first reported a position in Asensus Surgical, Inc. in Q4 2016 and held it in 7 quarters.
  • International Biotechnology Trust's Asensus Surgical, Inc. position peaked at $3.82M in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2018.

Based on International Biotechnology Trust's 13F filing for Q3 2018, filed 13 Nov 2018.